← CNBC Halftime Report hub  ·  Research hub  ·  Research library

CNBC Halftime Report — The State of the Tech Trade as SK Hynix Opens for Trading

Meta is the episode's centerpiece — Simpson opens a new growth-portfolio position, Weiss builds his "monster," biggest-ever stake (and will trim the recent adds), Harrington calls it "the only Mag-7 we still invest in" — all on Zuckerberg's pivot to sell the excess compute like a cloud. Around it: SK Hynix's record NASDAQ ADR debut (+16%), the memory investable-vs-tradeable fight over Micron, Weiss's "all roads lead to Taiwan Semi," Baruch's gold/miners buy on a walked-back-hawkishness thesis vs Harrington's gold-is-not-an-investment / copper-is counter, and the HSBC/Citi pre-print picks.
2026-JUL-10 · CNBC Halftime Report (audio edition) · host Scott Wapner; committee Steve Weiss, Jenny Harrington, Bill Baruch, Kevin Simpson · ~43 min · ▶ Listen · transcript · actionable insights
One-line take: The tech trade is now catalyst-driven (Weiss/Harrington: from here it's news, not flows), and Meta is the found catalyst — Zuckerberg reframing Meta's giant AI CapEx as an asset it can resell like AWS/Azure ("even if we don't need all the compute… you could sell it long term"), which flips the two-year "how does Meta monetize AI?" bear case. The committee piles in: Simpson new buy (growth portfolio), Weiss bought the down-89 open into his biggest-ever position (will trim the adds), Harrington added two weeks ago at $555, 20× earnings with $200B/yr social revenue still +28% — "the only Mag-7 we still invest in," Baruch "bottom of the ninth comeback," lowest PE since late '22. SK Hynix (SKHY) opens as the largest ADR listing ever ($26.5B raised, +16% over the $149 list to ~$173) — a 56–58% HBM-share pure-play and NVIDIA's #1 supplier (Christina's "direct line to NVIDIA") — but no one on the desk bought it. Memory splits the panel: Baruch (Micron = largest position, sold out through '26/'27, support 850–900, only a 20× rerating tops it) vs Weiss (took the profit Monday, rebuys ~925) vs Harrington ("trade it, it's not investable — cash flows too ambiguous"); Weiss's resolution: "all roads lead to Taiwan Semi" — capacity you pay for, spot-price-immune, the cheapest/most-predictable semi. Elsewhere: Weiss re-buys FTAI (engine-leasing → data-center power-gen, ~17× EBITDA cheap vs GEV, "orphan stock"); Baruch buys gold miners/GDX + OUNZ on July seasonality + a "Warsh hawkishness gets walked back into the midterms" catalyst, while Harrington says gold "is not an investment" but copper/Freeport is a clear cash-flow case; HSBC pre-print picks ABBV / CAT (Weiss sold half, "way overvalued") / MAR; Citi downgrades LAMR and PEP (GLP-1 + weak US consumer — Harrington wants it 20–30% lower, Simpson prefers KO). Finals: Weiss DKS, Harrington CLX, Baruch NBIS, Simpson NVDA (~$100B/qtr). Order: Positive → Neutral → Negative.

1. Stocks & names mentioned

Panel = CNBC's investment committee; "View" is the panel's net take this episode and the cell names which member(s) held it. This is an audio podcast — no (mm:ss) timestamps, so each "At" cell opens the Spotify episode (not a deep-link). Order: Positive → Neutral → Negative. Research: QT Qualtrim · SA Seeking Alpha · STK Stock Analysis.

TickerNameResearchViewWhat the committee saidAt
METAMeta PlatformsQT · SA · STK · FAPositiveThe episode's centerpiece, on Zuckerberg's pivot to resell excess AI compute like a cloud. Simpson NEW buy (growth portfolio) — "path to produce revenue," competes with Google/Amazon compute. Weiss bought the down-$89 open into his biggest-ever "monster" position (will trim the adds) — Zuck the lone visionary CEO, "paid so low he can sell at a premium." Harrington added 2wk ago @$555 — 20×, $200B/yr social rev +28%, "the only Mag-7 we still invest in." Baruch "bottom-of-the-ninth comeback," lowest PE since late '22.listen↗
NVDANvidiaQT · SA · STK · FAPositiveBaruch "loves what we're seeing — NVIDIA waking up right here," flat/digesting on the 200-day, putting new client cash to work (buying the target NVIDIA + Broadcom, "buys right here and it's going to run"). Simpson's final trade: Blackwell keeps outpacing, demand "unbelievable," finally approaching $100B/quarter.listen↗
AVGOBroadcomQT · SA · STK · FAPositiveBaruch is buying it alongside NVIDIA as he puts new money to work — "I'm trading the target, NVIDIA, Broadcom… these are buys right here and it's going to run."listen↗
TSMTaiwan SemiconductorQT · SA · STK · FAPositiveWeiss's resolution to the messy semi/memory debate: "all roads lead to Taiwan Semi" — whether it's Meta, Apple or NVIDIA making the chip, they all need TSMC capacity. The cheapest and most predictable semi because it doesn't price off volatile spot markets: "you want their capacity, you pay for it, and that's it."listen↗
FTAIFTAI AviationQT · SA · STK · FAPositiveWeiss re-bought it (had traded it 40s→110, back in the 90s, sold out in May) on the pivot from aircraft-engine leasing/maintenance into power generation — "aircraft engines are being used to power data centers." ~17× EBITDA (cheap vs GEV), teens PE on '27, an under-followed "orphan stock," part of the AI trade. Down on the recent add but "pretty good upside"; "not going to ride this down."listen↗
FCXFreeport-McMoRanQT · SA · STK · FAPositiveHarrington's copper play — "copper's different" from gold: endless demand as we build data centers and EVs, a "clear-cut" case that copper miners are "terribly productive and make lots of cash." Baruch also increased copper miners: copper in a supply deficit that widens over time, "miners there set up pretty well."listen↗
GDXVanEck Gold Miners ETFQT · SA · STKPositiveBaruch bought more of the miners: July gold seasonality picking up, a constructive chart, and his key catalyst — Warsh's "misunderstood" hawkishness (30% July-hike / 50% year-end odds priced) getting "incrementally walked back… into the midterms." Harrington's counter is on gold itself: "too speculative… not an investment."listen↗
OUNZVanEck Merk Gold ETFQT · SA · STKPositiveBaruch's physical-gold vehicle: in January he sold CEF into OUNZ to cut the silver exposure ("great timing"); part of the same gold-add on seasonality + the walked-back-hawkishness thesis. Gold's 2026 drawdown he pins on Basel III (tier-1 status → oil-exporter balance-sheet selling), not a broken thesis.listen↗
ABBVAbbVieQT · SA · STK · FAPositiveAn HSBC top pick into the prints, and Baruch's #15 name: Skyrizi and Rinvoq have replaced the lost Humira revenue, ~24% revenue growth expected, stock trying to break out (+7% ytd). "I like healthcare quite a bit, outside of tech."listen↗
LLYEli LillyQT · SA · STK · FAPositiveBaruch, in the AbbVie/healthcare aside: "I like Lilly a lot as well" — sees great momentum continuing in healthcare outside of tech.listen↗
KOCoca-ColaQT · SA · STK · FAPositiveSimpson's conviction beverage name over Pepsi: a huge position in the dividend portfolio, +20% on the year. "I like Coke" — where his conviction sits vs the downgraded PEP.listen↗
UNHUnitedHealth GroupQT · SA · STK · FAPositiveWeiss's earnings-setup pick (reports next Thursday): with Steve Hemsley back as CEO he expects continued upside beats — Hemsley "ruthless in getting cost under control," going back to what made it a permanent compounder.listen↗
FASTFastenalQT · SA · STK · FAPositiveBaruch owns it (reports next Monday): "a real gauge on the US industrial economy," benefiting from reshoring and energy — "high hopes they can do well here."listen↗
SBRASabra Health Care REITQT · SA · STK · FAPositiveHarrington's example of the predictability she wants (vs "ambiguous" memory): a portfolio holding 90% leased to skilled nursing / retirement communities — "far more predictability on that." Lower expected return than a semi, but knowable.listen↗
TERTeradyneQT · SA · STK · FAPositiveHarrington owns it on the testing-complexity thesis: "everything needs to go back to testing, and the more complicated chips get, the harder and more important testing is" — her preferred way into the semi story vs the harder-to-value memory names.listen↗
DKSDick's Sporting GoodsQT · SA · STK · FAPositiveWeiss's final trade: the stock's corrected a little and "has these peaks and valleys," but it's "still the top play in retail in my view."listen↗
CLXCloroxQT · SA · STK · FAPositiveHarrington's final trade: a dividend aristocrat with a 5% yield at 17× earnings; as petrochemicals (its biggest cost) return to pre-war pricing and supply chains normalize, "this stock should get a pop."listen↗
NBISNebius GroupQT · SA · STK · FAPositiveBaruch's final trade: an AI-infrastructure "ultra-growth story" that's sold off 40% from its recent high into big support — "I think it snaps back quickly." Notes the super-volatile area.listen↗
MARMarriott InternationalQT · SA · STK · FAPositiveAn HSBC top pick; Harrington's owned it in the growth strategy since 2013 — a "permanent compounder" with reliable mid-teens earnings for the next three years, "hold for a decade or more." Caveat: expensive at 30× / 3.5% FCF yield, +22% ytd — "maybe you don't buy it here… wait for a blip."listen↗
MUMicron TechnologyQT · SA · STK · FANeutralSplit: Baruch's largest position (sold out through 2026, HBM likely into '27, ~40%+; support 850–900; stays a low multiple — only a 20× rerating would top it), vs Weiss (took profit Monday off a 350 cost, "didn't want to be piggish," rebuys ~925), vs Harrington ("you trade it, I'm not sure it's investable — cash flows too ambiguous," a 100% run already prices '27–'28). All agree a 20× multiple is where it "gets egregious."listen↗
SKHYSK Hynix (ADR)QT · SA · STK · FANeutralMarket color, no committee position: the largest ADR listing ever in the US — $26.5B raised, opened well above the $149 list at ~$173 (+16%), 177M shares. Christina frames it as a bigger/cheaper/closer-to-NVIDIA-than-Micron pure-play on high-bandwidth memory — 56–58% HBM share (Samsung/Micron ~21%), NVIDIA's #1 supplier, "the direct line to NVIDIA." Weiss notes it's a slightly lower valuation than Micron but didn't buy; open funding source (Micron/chips/foreign ADRs) is the open question.listen↗
CATCaterpillarQT · SA · STK · FANeutralAn HSBC top pick, but the desk splits: Simpson holds (a multiyear power-gen / mining-infrastructure play, not just AI-adjacent; +65% ytd, +132% 12mo, "we're not selling") yet won't add — at his 5% max and "up against the threshold to perfection." Weiss sold half — "way overvalued." Simpson would still "buy it on all weakness."listen↗
SpaceXSpaceXNeutral(Private.) Now public and trading below its first-trade price (~$148, −3% on the day) since the recent IPO. Simpson owns a small position (down on it) — bull case is Falcon/Starlink near-monopoly + the "Elon premium," would "double down for sure" closer to $100; sees under-the-surface Tesla synergy without a formal merger. Baruch on-radar (avoids just-public names in model portfolios) but excited by the story — Colossus supercomputer + the Cursor acquisition training the models, scalable to 1 terawatt — while warning these names "sell off 50 to 70%." Musk postponed the Boorstin interview.listen↗
TSLATeslaQT · SA · STK · FANeutralSimpson owns it in the growth portfolio alongside SpaceX — deliberately holding both on the view that even without a legal merger, "a lot of a merger has already taken place" via shared AI (Grok/X). No fresh buy/sell; a high-multiple, ride-the-ebbs-and-flows name.listen↗
LAMRLamar AdvertisingQT · SA · STK · FANeutralDowngraded to neutral from buy at Citi (target $160, ~where it trades). Harrington owns it in the dividend strategy and is torn: +30% ytd, a huge capital gain, dividend down to 4%, "pretty expensive… not much upside left" (the analyst agrees) — but a high-quality, "indelible" billboard business. "I'm not selling it yet, but I'm not too far off."listen↗
CRCLCircle Internet GroupQT · SA · STK · FANeutralRenick's options color: a bullish call frenzy on the National Trust bank approval — options volume 4× the 30-day average, ~200k contracts, 78% calls (top-five all expire today, 59–80 low-probability strikes) — but the biggest single trade was bearish (selling Aug-21 85 calls to fund $500k of 55-strike puts). Stock +5% on the day yet still −70% over the past year.listen↗
MAGSRoundhill Magnificent Seven ETFQT · SA · STKNeutralHartnett's (BofA) flow gauge: the Mag-7 ETF is still "the key to this overall rally" so long as it holds its 200-day at 65 (trading 67.53) — above it, investors reload longs / bullishly rotate rather than retreat from risk. A reference line, not a committee pick.listen↗
OpenAIOpenAINeutral(Private.) Macro AI-cost color via Boorstin: in her prior-day Sam Altman interview he touted OpenAI's new models being much more efficient — part of an industry-wide "moment" where every AI player (Grok 4.5 too) is focused on cost efficiency as component costs rise. No committee stance.listen↗
PEPPepsiCoQT · SA · STK · FANegativeDowngraded to neutral from buy at Citi (target $145 from $170). Simpson agrees — North American demand "atrocious," a tiny Russell-1000-growth index position he holds only for the benchmark, "wouldn't get in front of it" (conviction is in KO). Harrington wanted it for the 4.4% yield but "kept hitting roadblocks" — GLP-1s (a huge snack business) + a weakening US consumer; needs it 20–30% lower to warrant the valuation. Reminds Simpson of Nike.listen↗

"View" = the panel's net stance this episode, with the committee member named in the note. Discussed only as context (not tabled): Samsung (memory-complex #3, ~21% HBM share and "catching up"; got "slammed" on its print this week); GEV (GE Vernova, as a valuation yardstick for FTAI); Grok 4.5 / xAI and legacy GLD / SLV (AI-cost-efficiency and gold-speculation asides); the unnamed "Barron's dividend-trim / GLP-1 / 8.5× earnings" setup name (see anomaly note below). People not tabled: Scott Wapner & the committee, Christina Partsinevelos, Mike Santoli, Oliver Renick, Julia Boorstin, Kate Rooney, Michael Hartnett, Kevin Warsh, Jamie Dimon, Elon Musk, Sam Altman, Mark Zuckerberg, Steve Hemsley.

2. Talking points

Catalyst-driven tape — the marginal buyer question

Baruch: "capitulation on the CapEx fear" has reversed

Harrington's blowout-or-plateau earnings frame

Meta — the found catalyst (Zuckerberg's resell-the-compute pivot)

Musk postpones; SpaceX below its first trade; the AI cost-efficiency moment

SpaceX — how to own it, and the Tesla-synergy question

SK Hynix opens — the record ADR and the "direct line to NVIDIA"

Memory: investable or just tradeable? (the panel's core fight)

Committee move — Weiss re-buys FTAI

Committee move — Baruch buys gold miners/GDX + OUNZ (walked-back hawkishness)

Gold vs copper — Harrington's line

Santoli's midday word — high bar, benign tape

HSBC top picks & Citi downgrades into the prints

Options tape & earnings setups

Final trades

3. In plain English

A jargon-free summary of why each substantively-argued name matters. (These render on each ticker's consolidated page, where this audio episode has no excerpt to pull.)

META — Meta Platforms Positive

Meta owns Facebook, Instagram and WhatsApp, and for two years investors punished it for spending enormous sums on AI without a clear way to make money from it. The turning point this week: Zuckerberg said the giant pile of computing power Meta is building is a "backstop" it can rent out to other companies — the same business Amazon (AWS), Microsoft (Azure) and Google run. So the spending that looked like a black hole is being reframed as an asset Meta can resell at a profit, and Meta bought that compute cheaply.

The whole committee moved in on that idea. Kevin Simpson opened a brand-new position; Steve Weiss bought aggressively on a down day into his biggest position ever (and plans to trim the newest adds); Jenny Harrington, who added two weeks ago, calls it "the only Mag-7 we still invest in" — 20× earnings with a social-media business still throwing off $200 billion a year growing 28%; Bill Baruch calls it a "bottom-of-the-ninth comeback" at the cheapest valuation since late 2022.

MU — Micron Technology Neutral

Micron makes memory chips that AI servers need in bulk. After a huge run the committee openly disagrees on it. Bill Baruch's largest position — he argues the company is "sold out" of capacity through 2026 (and its high-end AI memory likely into 2027), so earnings are locked in; he'd only call a top if the stock re-rates to 20× earnings (it usually trades far cheaper). Steve Weiss made a fortune on it but sold Monday to bank the gain ("didn't want to be piggish") and would only buy back around $925.

Jenny Harrington is the skeptic: a stock that has already doubled is "pricing in" the best case for 2027–2028, competition is intense, and a single software breakthrough could cut how much memory AI needs — so the future cash flows are "too ambiguous." Her verdict: "you trade it, it's not investable." Net: a name to rent, not marry — hence the Neutral.

SKHY — SK Hynix (ADR) Neutral

SK Hynix is the Korean memory-chip giant that dominates "high-bandwidth memory" (HBM) — the specialized memory stacked next to NVIDIA's AI chips. It just started trading in the US as an ADR (a US-listed receipt that lets Americans buy a foreign company's shares), and it was the largest such listing ever: $26.5 billion raised, opening 16% above its $149 offer price at about $173.

The bull framing (from CNBC's Christina Partsinevelos) is that it's a bigger, cheaper, more direct bet on NVIDIA's supply chain than Micron — SK Hynix holds 56–58% of the HBM market vs about 21% each for Samsung and Micron, and is NVIDIA's number-one supplier. But it's market color, not a recommendation: no one on the committee bought it, and Weiss only noted it's slightly cheaper than Micron. An open question is where all the buying money is coming from (possibly rotated out of Micron and other chips).

NVDA — Nvidia Positive

Nvidia makes the chips that train and run AI. After going nowhere for a month (flat/slightly up on the year), Bill Baruch likes that it's "waking up" while holding a key trend line, and is putting new client money to work in it (alongside Broadcom). Kevin Simpson made it his final-trade pick, noting demand for the new Blackwell chips is "unbelievable" and the company is finally approaching $100 billion of revenue per quarter.

AVGO — Broadcom Positive

Broadcom makes networking chips and custom AI silicon for the big cloud companies. Bill Baruch is buying it right alongside Nvidia as he deploys new cash — "these are buys right here and it's going to run" — treating the pair as his way to re-enter the AI-chip trade after its recent pause.

TSM — Taiwan Semiconductor Positive

Taiwan Semiconductor is the factory that actually manufactures the advanced chips designed by Nvidia, Apple, Meta and others — nobody can make leading-edge chips without it. Steve Weiss's point is that however messy the memory debate gets, "all roads lead to Taiwan Semi": everyone needs its capacity, so it captures value no matter which chip designer wins.

He also likes that it's more predictable than most chip stocks: it doesn't price its output off volatile spot-market prices — you reserve its capacity and pay a set price — which makes its earnings steadier and, in his view, makes it the cheapest and most reliable semiconductor to own.

FTAI — FTAI Aviation Positive

FTAI used to be a fairly boring business — leasing and maintaining aircraft engines. Steve Weiss re-bought it because it has quietly transformed into a power-generation company: it turns out jet engines can be repurposed to generate electricity, and that electricity is in huge demand to power AI data centers. So an old aviation name is now part of the AI-power story.

His case is that it's cheap and overlooked: it trades around 17× EBITDA (a measure of cash earnings) — much cheaper than a comparable power name like GE Vernova — and would be in the teens on a normal earnings basis using 2027 estimates. He calls it an "orphan stock" because few analysts follow it. He's down on his recent purchase but sees good upside and won't panic-sell it lower.

GDX — VanEck Gold Miners ETF Positive

GDX is a basket of gold-mining stocks. Bill Baruch bought more after gold's worst quarter since 2013, for two reasons: gold tends to do well seasonally in July, and — his bigger bet — he thinks the Fed under Kevin Warsh only sounds hawkish (markets price a 30% chance of a July rate hike, 50% by year-end). Baruch expects that tough talk to be "walked back" to boost the economy and stock market ahead of the midterm elections, which would be bullish for gold.

Jenny Harrington flatly disagrees on gold itself — she says there's no way to value it and "it's not an investment," just a bet on other people's behavior. So this is a split-desk call: bullish from the buyer, dismissive from the fundamental investor.

OUNZ — VanEck Merk Gold ETF Positive

OUNZ is a fund that holds physical gold (it even lets holders redeem for real coins/bars). Bill Baruch uses it as his gold vehicle — back in January he swapped out of a different fund (CEF) into OUNZ specifically to drop the silver exposure, and he's now adding on the same seasonal + "Fed hawkishness gets walked back" thesis.

His explanation for why gold fell in 2026 despite all this: a rule change (Basel III) made gold a top-tier bank asset, and cash-strapped oil-exporting nations have been selling their gold reserves to raise money — a mechanical, temporary source of selling, not a sign the long-term case is broken.

FCX — Freeport-McMoRan Positive

Freeport is one of the world's biggest copper miners. Jenny Harrington draws a sharp line between copper and gold: unlike gold, copper has a "clear-cut" cash-flow case because demand is relentless — every data center and every electric car needs a lot of it — so the miners are highly profitable and that's easy to model. She'd even rather own a copper miner than gold outright.

Bill Baruch agrees on copper specifically: he sees a supply deficit that widens over time, which sets the miners up well. So copper is the one part of the metals trade both the fundamentalist and the trader like.

ABBV — AbbVie Positive

AbbVie is a big pharmaceutical company. The worry for years was that its blockbuster drug Humira would lose patent protection and crater revenue — but Bill Baruch (it's his #15 position, and HSBC just named it a top pick) says two newer drugs, Skyrizi and Rinvoq, have already replaced that lost revenue, with ~24% revenue growth expected. The stock is trying to break out, and he likes healthcare (and Eli Lilly) as a place to be outside of tech.

KO — Coca-Cola Positive

Faced with a choice between the two beverage giants, Kevin Simpson's conviction is firmly with Coca-Cola over Pepsi. It's a large position in his dividend portfolio and is up 20% this year. The contrast is the point: while Pepsi's North American demand is weak and it's being downgraded, Coke is executing — so he's happy to hold the winner and avoid the laggard.

CAT — Caterpillar Neutral

Caterpillar makes heavy machinery and, increasingly, power-generation and mining equipment tied to the data-center buildout. HSBC named it a top pick, but the committee is split, which nets out to Neutral. Kevin Simpson holds it as a multi-year story and won't sell — but he's at his 5% position limit and wouldn't add, calling it "up against the threshold to perfection" (priced for everything going right). Steve Weiss went the other way and sold half, calling it "way overvalued" after a 65% run this year. Simpson would still add on any real weakness.

MAR — Marriott International Positive

Marriott is the global hotel operator. Jenny Harrington has owned it since 2013 and calls it a "permanent compounder" — the kind of predictable business (reliable mid-teens earnings growth expected for the next three years) you can hold for a decade or more, which she contrasts with the "ambiguous" memory stocks. HSBC also named it a top pick.

Her one caveat is price: it's expensive at 30× earnings with only a 3.5% free-cash-flow yield and is up 22% this year, so she'd "wait for a blip" rather than chase it here. A high-quality long-term hold, just not an add at today's level.

CLX — Clorox Positive

Clorox is the consumer-products maker (bleach, cleaning supplies). Jenny Harrington's final-trade pick: it's a "dividend aristocrat" (a company with a long record of raising its dividend) yielding 5% at a reasonable 17× earnings. Her catalyst is costs — petrochemicals are its biggest input, and as those prices fall back toward pre-war levels and supply chains normalize, margins should improve and "this stock should get a pop."

NBIS — Nebius Group Positive

Nebius is a fast-growing AI-infrastructure company (it rents out AI computing capacity). Bill Baruch's final-trade pick: it's an "ultra-growth" story that has sold off 40% from its recent high into what he sees as strong technical support, and he expects it to "snap back quickly." He flags it's a very volatile part of the market.

SpaceX — SpaceX Neutral

SpaceX, Elon Musk's rocket-and-satellite company, recently went public and is already trading below its very first trade (around $148). Kevin Simpson owns a small, losing position and would "double down" only if it fell closer to $100 — the bull case being the near-monopoly of its Falcon rockets and Starlink internet, plus a premium for Musk himself. He deliberately also owns Tesla, betting the two effectively merge "under the surface" through shared AI even without a formal deal.

Bill Baruch doesn't own it (he avoids just-public stocks in his model portfolios) but is excited by the technology — its Colossus supercomputer and a "Cursor" acquisition are training its AI models, with room to scale enormously. His caution: newly public high-flyers routinely fall 50–70%, so he'd wait a few months. Net: an interesting story, but nobody's a confident buyer at today's price — hence Neutral.

LAMR — Lamar Advertising Neutral

Lamar owns billboards and is structured as a REIT (a real-estate company that pays out most income as dividends). Citi just downgraded it to neutral. Jenny Harrington owns it and is genuinely torn: it's up over 30% this year (leaving her a big taxable gain), the dividend yield has fallen to 4%, and both she and the analyst see limited upside left because it's gotten expensive.

But she loves the business — billboards are the one ad medium people can't skip — with excellent management. So she's stuck between banking the gain (and swapping into a higher 5% yield) and holding a great company: "I'm not selling it yet, but I'm not too far off."

PEP — PepsiCo Negative

Pepsi was downgraded by Citi, and the committee agrees it's one to avoid for now. Kevin Simpson only holds a tiny sliver because it's part of an index he tracks — North American demand has been "atrocious," and his real conviction is in Coca-Cola instead. Jenny Harrington was tempted by the rising 4.4% dividend yield but kept "hitting roadblocks" in her research.

The two big worries: GLP-1 weight-loss drugs (which threaten Pepsi's huge snack business, not just its drinks) and a weakening US consumer, with North American results faltering again in the latest quarter. She thinks the stock needs to fall another 20–30% before its valuation is compelling. It reminded Simpson of Nike — a quality brand whose stock still had further to fall.


Summary derived from the public CNBC Halftime Report audio episode (transcript in transcript.txt) for personal study. Not investment advice. © CNBC for source material.